EP Patent

EP0641562A1 — Nutritional supplement

Assigned to Novartis AG · Expires 1995-03-08 · 31y expired

What this patent protects

Method of stimulating the immune system of patients suffering from HIV-related infection, by administering a nutritional supplement and the use of omega-3 PUFA and a compound associated with the synthesis of polyamines in the manufacture of such supplement.

USPTO Abstract

Method of stimulating the immune system of patients suffering from HIV-related infection, by administering a nutritional supplement and the use of omega-3 PUFA and a compound associated with the synthesis of polyamines in the manufacture of such supplement.

Drugs covered by this patent

Patent Metadata

Patent number
EP0641562A1
Jurisdiction
EP
Classification
—
Expires
1995-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.